PMDA drug package insert
バップフォー錠10
PMDA Prescription drug · 大鵬薬品工業株式会社 · package insert Aug 10, 2021
Key facts
| Brand names | バップフォー錠10, バップフォー錠20, バップフォー細粒2% |
|---|---|
| Nonproprietary names | プロピベリン塩酸塩 |
| Companies | 製造販売元／大鵬薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 尿失禁; 頻尿; 過活動膀胱治療剤 |
| Therapeutic category codes | 87259 |
| YJ codes | 2590007F1021, 2590007F2028, 2590007C1025 |
| Approval numbers | 20500AMZ00143000, 20500AMZ00142000, 21800AMZ10046000 |
| Package insert edition | 第2版 |
| Package insert date | Aug 10, 2021 |
| PMDA document key | 400107_2590007C1025_1 |
| PMDA company code | 400107 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: